Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SQUARE PD: Sequential Multiple Assignment Randomized Trial to Treat Urinary Symptoms in Parkinson Disease
NCT07187466Phase 4Not yet recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Nov 2026
- Primary completion
- Mar 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirabegron in overactive bladder (OAB), sponsored by VA Office of Research & Development. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT07187466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07187466.